- Houlihan Lokey is defending its mid-cap investment-banking franchise while selectively moving up in deal and fee size.
- The firm is expanding internationally, targeting Europe to rise from about 25% of revenue toward 35–40% over time.
- Diversified businesses in corporate finance, restructuring, and valuation have supported strong recent revenue growth and steadier results across cycles.
- Growth is being driven by targeted senior hires and acquisitions, even as competition intensifies from bulge brackets moving down-market and boutiques moving up.
Read More
Strategic Positioning and Trends
Houlihan Lokey (HLI) is executing a multi-pronged strategy aimed at sustaining its leadership in mid-cap investment banking while capitalizing on global and macro trends. Under CEO Scott Adelson, the firm continues to build on a model of diversification—by geography, by business line, and by sector specialization—that has delivered above-market growth. Its revenue growth of 24% in Q3 fiscal 2025 and 15% year-over-year in Q2 fiscal 2026 reflects both deal-flow rebound and higher fees per deal.
Mid-Market Core vs. Deal Size Expansion
An internal tension exists between staying true to the mid-cap mandate—deals under ~$1 billion—and growing towards larger deal sizes and fees. Adelson emphasizes that while the firm is “squarely focused on the mid cap space”, there is a discernible and deliberate increase in average deal and fee size over time. This suggests that HLI seeks to maintain its niche but stretch the envelope in select situations—perhaps in sub-$1-1.5 billion range—to capture more value.
Geographic Expansion: Europe and Asia Pacific
A key pillar of HLI’s growth is its expansion in EMEA and Asia-Pacific. Europe already accounts for ~25% of revenue and the firm has declared objectives to expand that to 35-40% in the longer term. The firm has been executing via acquisitions of boutiques, targeted senior bankers, and expanding sector coverage to build regional heft. Management compares the European fee pool potential to that of the U.S., though with caveats about regulatory, competitive, and cultural differences.
Business Segment Strengths and Counter-Cyclical Buffering
Houlihan Lokey’s three main business lines—Corporate Finance (~65% of revenues), Financial Restructuring (~22-23%), and Financial & Valuation Advisory (~13%) — are contributing to stable growth. Importantly, its restructuring arm provides counter-cyclical strength in down markets, balancing Corporate Finance volatility. HLI’s ability to generate deal flow even amid tariff-induced uncertainty and macro volatility is a competitive differentiator.
Competition and Risks
Competition continues to intensify. Bulge-bracket banks are entering mid-market territory with scale; boutiques are improving their capabilities; and competition in capital solutions and secondaries is especially pronounced. Regulatory risks, geopolitical uncertainty, and macroeconomic factors like interest rates and capital availability remain material risks that could affect deal flow and profitability.
Strategic Implications
- HLI must maintain disciplined hiring and acquisition strategies that not only bring industrial or product expertise but also ensure cultural alignment to avoid integration combustion.
- To sustainably push up deal size, HLI will need to continue investing in senior talent and possibly develop specialized practice groups that compete more directly with larger banks.
- Regulatory and competitive headwinds in Europe will require strong compliance, localization strategies, and possibly different deal structures compared to the U.S. market.
- Maintaining a stable restructuring segment and expanding GP-led secondaries gives HLI more defensive optionality, helping smooth earnings during hard macro cycles.
Open Questions
- How quickly can Europe reach parity with U.S. fee pool contribution without compressing margins due to competition and regulation?
- What is the threshold above which HLI risks losing its “mid-cap specialist” identity if deal size grows too aggressively?
- Will rising interest rates or capital costs materially delay or shrink the mid-cap deal pipeline despite strong current activity?
- Can HLI maintain its expense discipline (compensation, non-comp costs) as it hires senior bankers globally and acquires boutiques?
- How exposed is the restructuring segment if rates rise sharply or economic conditions sharply reverse?
Supporting Notes
- Corporate Finance revenue rose 36% YoY in Q3 2025 to approximately $422 million, driving overall revenue growth of 24% to $634 million.
- Q2 fiscal 2026 revenue was $659 million, up 15% vs Q2 2025; Corporate Finance grew ~21% YoY.
- Revenue segmentation: Corporate Finance ≈65%, Financial Restructuring ≈22–23%, Financial & Valuation Advisory ≈13%.
- Number of Managing Directors: ~244 in Corporate Finance in Q1 fiscal 2026 (up from 228 YoY); mid-cap hiring remains active.
- EMEA revenue accounts for ~25% of total; long-term target of 35-40% in Europe.
- Acquisitions: Waller Helms Advisors added 13 MDs in financial services; Prytania Solutions adds tech-enabled valuation work; Triago strengthens private funds/secondaries coverage.
- Deal volume leadership: 415 global M&A deals in 2024, ahead of Rothschild & Co and Goldman Sachs; strong showings across restructuring and fairness opinions.
- PPE segments per MD productivity in restructuring remains high: ~$9.5 million revenue per Managing Director.
- Expense discipline: adjusted compensation ratio ~61.5% in Q2 fiscal 2025 and prior year; non-compensation expense ratio held at ~14–16%.
- CEO quote on competition in Capital Solutions and private capital: competition from other mid-cap players; belief in continuing meaningful growth of capital markets business.
